NCT03167905 - CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery) | Biotech Hunter

Enrollment

881

Participants

Timeline

Start Date

June 15, 2017

Primary Completion Date

July 19, 2021

Study Completion Date

December 31, 2026

Conditions

Depression, PostpartumAnalgesia, ObstetricalAnesthesia, Obstetrical

Interventions

DEVICE

Epidural delivery system

Epidural delivery system for maintenance of labour epidural analgesia using 0.1% ropivacaine (amide local anaesthetic) with 2mcg/ml fentanyl (opioid) as maintenance solution.

DRUG

Entonox

Entonox will be given upon request in non-epidural group.

DRUG

Meperidine

Intramuscular pethidine (75mg/1.5ml) will be given upon request in non-epidural group.

DRUG

Ultiva

Intravenous patient controlled remifentanil (20-40mcg/ml) is only given when the patient rejects or cannot receive pethidine and entonox in non-epidural group..

DRUG

Fentanyl

Epidural delivery system for maintenance of labour epidural analgesia using 0.1% ropivacaine (amide local anaesthetic) with 2mcg/ml fentanyl (opioid) as maintenance solution.

DRUG

Ropivacaine

Epidural delivery system for maintenance of labour epidural analgesia using 0.1% ropivacaine (amide local anaesthetic) with 2mcg/ml fentanyl (opioid) as maintenance solution.

Trial Locations (1)

229899

KK Women's and Children's Hospital, Singapore

All Listed Sponsors

lead

KK Women's and Children's Hospital

OTHER_GOV